Cargando…
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
The acronym THERANOSTICS epitomizes the inseparability of diagnosis and therapy, the pillars of medicine and takes into account personalized management of disease for a specific patient. Molecular phenotypes of neoplasms can be determined by molecular imaging with specific probes using positron emis...
Autores principales: | Baum, Richard P., Kulkarni, Harshad R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360197/ https://www.ncbi.nlm.nih.gov/pubmed/22768024 http://dx.doi.org/10.7150/thno.3645 |
Ejemplares similares
-
1(st) World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23–26, 2011, Zentralklinik Bad Berka, Germany
por: Baum, Richard P., et al.
Publicado: (2011) -
Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021) -
Juvenile Nasal Angiofibroma on (68)Ga-DOTANOC PET/CT: Exploring Theranostic Avenues
por: Sakthivel, Pirabu, et al.
Publicado: (2020) -
Peptide-Based [(68)Ga]Ga Labeled PET Tracer for Tumor Imaging by Targeting Tumor-Associated Macrophages
por: Huang, Mingxing, et al.
Publicado: (2022) -
Dynamic PET/CT with the Hepatobiliary Tracer [68Ga]Ga-Tmos-DAZA for Characterization of a Hepatic Tumor
por: Freesmeyer, Martin, et al.
Publicado: (2021)